anmelden
BX Swiss TOP 30 CHF
1.371,11
PKT
-4,74
PKT
-0,34
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 19.01.15 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 19.01.15 | UBS buy | Kepler Cheuvreux | |
| 19.01.15 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 19.01.15 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 19.01.15 | Nestlé Hold | Kepler Cheuvreux | |
| 19.01.15 | ABB (Asea Brown Boveri) Hold | Kepler Cheuvreux | |
| 19.01.15 | UBS neutral | Kepler Cheuvreux | |
| 19.01.15 | Givaudan buy | Kepler Cheuvreux | |
| 19.01.15 | Holcim buy | Kepler Cheuvreux | |
| 19.01.15 | Zurich Insurance buy | Goldman Sachs Group Inc. | |
| 16.01.15 | ABB (Asea Brown Boveri) Halten | Independent Research GmbH | |
| 16.01.15 | Zurich Insurance neutral | DZ-Bank AG | |
| 16.01.15 | Roche Hold | S&P Capital IQ | |
| 16.01.15 | ABB (Asea Brown Boveri) Sell | Société Générale Group S.A. (SG) | |
| 16.01.15 | UBS Strong Buy | S&P Capital IQ | |
| 16.01.15 | Nestlé Sell | S&P Capital IQ | |
| 16.01.15 | Novartis buy | UBS AG | |
| 16.01.15 | Roche Neutral | UBS AG | |
| 16.01.15 | Novartis buy | Jefferies & Company Inc. | |
| 16.01.15 | Zurich Insurance Underperform | Bernstein Research | |
| 16.01.15 | Roche buy | Jefferies & Company Inc. | |
| 16.01.15 | Novartis buy | S&P Capital IQ | |
| 16.01.15 | Swiss Re Hold | Société Générale Group S.A. (SG) | |
| 16.01.15 | Zurich Insurance Sell | Société Générale Group S.A. (SG) | |
| 16.01.15 | Swiss Re Verkaufen | DZ-Bank AG | |
| 16.01.15 | Roche overweight | Barclays Capital | |
| 16.01.15 | Nestlé Neutral | Credit Suisse Group | |
| 16.01.15 | Nestlé Hold | Deutsche Bank AG | |
| 16.01.15 | Holcim buy | Deutsche Bank AG | |
| 16.01.15 | Givaudan buy | Deutsche Bank AG | |
| 16.01.15 | Nestlé Underperform | BNP PARIBAS | |
| 16.01.15 | ABB (Asea Brown Boveri) Underperform | BNP PARIBAS | |
| 16.01.15 | Holcim overweight | JP Morgan Chase & Co. | |
| 16.01.15 | Nestlé overweight | JP Morgan Chase & Co. | |
| 16.01.15 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 16.01.15 | Givaudan overweight | JP Morgan Chase & Co. | |
| 16.01.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.01.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 16.01.15 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 16.01.15 | UBS buy | Goldman Sachs Group Inc. |